Feng Chi Biotech (ROCO:6744) Total Stockholders Equity : NT$238.0 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Total Stockholders Equity?

Feng Chi Biotech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$238.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Feng Chi Biotech's Book Value per Share for the quarter that ended in Dec. 2023 was NT$15.45. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Feng Chi Biotech's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.05.

Feng Chi Biotech Total Stockholders Equity Historical Data

The historical data trend for Feng Chi Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Total Stockholders Equity Chart

Feng Chi Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

213.55

225.08

230.51

235.87

238.00

Feng Chi Biotech Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial									230.51	225.06	235.87	228.39	238.00

Feng Chi Biotech (ROCO:6744) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Feng Chi Biotech's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(237.998	-	0)	/	15.4
	=	15.45

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Feng Chi Biotech's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.649	+	8.149)	/	237.998
	=	0.05

Feng Chi Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Feng Chi Biotech (ROCO:6744) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100

Website

http://www.fcbiotech.com.tw

Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines